A detailed history of Ameriprise Financial Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 122,602 shares of TMDX stock, worth $9.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122,602
Previous 57,736 112.35%
Holding current value
$9.92 Million
Previous $8.7 Million 121.34%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $8.8 Million - $11.4 Million
64,866 Added 112.35%
122,602 $19.2 Million
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $3.47 Million - $7.21 Million
-47,846 Reduced 45.32%
57,736 $8.7 Million
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $2.08 Million - $2.64 Million
-29,340 Reduced 21.75%
105,582 $7.81 Million
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $30,383 - $67,053
-827 Reduced 0.61%
134,922 $10.6 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $1.2 Million - $2.15 Million
-22,354 Reduced 14.14%
135,749 $7.43 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $1.22 Million - $1.63 Million
18,412 Added 13.18%
158,103 $13.3 Million
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $683,246 - $1.05 Million
12,740 Added 10.04%
139,691 $10.6 Million
Q4 2022

Feb 14, 2023

BUY
$39.08 - $64.29 $2.16 Million - $3.56 Million
55,299 Added 77.18%
126,951 $7.84 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $2.26 Million - $3.99 Million
71,652 New
71,652 $2.99 Million
Q4 2021

Feb 14, 2022

SELL
$19.16 - $32.68 $115,668 - $197,289
-6,037 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $12,312 - $16,392
-475 Reduced 7.29%
6,037 $200,000
Q2 2021

Aug 16, 2021

SELL
$21.63 - $40.07 $113,449 - $210,167
-5,245 Reduced 44.61%
6,512 $216,000
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $208,686 - $562,219
11,757 New
11,757 $488,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.